Back to VANGUARD GROUP INC VANGUARD GROUP INC

UTHRUTHR
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in UNITED THERAPEUTICS CORP DEL

As of its last 13F, for Q4 2025, Vanguard Group held 4,176,016 shares of UTHR (United Therapeutics), worth $2B. It reduced the position by 242,594 shares (-5.5%) from Q3 2025. Vanguard Group held UTHR from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$2B

Current Shares

4.2M

Total Value Change

+$454.6M

Total Shares Change

-233,594

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
4.2M
-5.5%
$2B0.0%$487.25
0
2025-Q3
Decreased
4.4M
-0.7%
$1.9B0.0%$419.21
0
2025-Q2
Decreased
4.4M
-0.2%
$1.3B0.0%$287.35
0
2025-Q1
Increased
4.5M
+0.3%
$1.4B0.0%$308.27
32
2024-Q4
Increased
4.4M
+0.7%
$1.6B0.0%$352.84
32
2024-Q3
First report
4.4M
-
$1.6B0.0%$358.35
0

Other major holders of UTHR: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used